Literature DB >> 28867731

FOXA1 Induces E-Cadherin Expression at the Protein Level via Suppression of Slug in Epithelial Breast Cancer Cells.

Erina Anzai1, Kensuke Hirata1, Misato Shibazaki1, Chiaki Yamada1, Mariko Morii1, Takuya Honda1, Naoto Yamaguchi1, Noritaka Yamaguchi1.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is an important process during embryonic development and tumor progression by which adherent epithelial cells acquire mesenchymal properties. Forkhead box protein A1 (FOXA1) is a transcriptional regulator preferentially expressed in epithelial breast cancer cells, and its expression is lost in mesenchymal breast cancer cells. However, the implication of this biased expression of FOXA1 in breast cancer is not fully understood. In this study, we analyzed the involvement of FOXA1 in EMT progression in breast cancer, and found that stable expression of FOXA1 in the mesenchymal breast cancer MDA-MB-231 cells strongly induced the epithelial marker E-cadherin at the mRNA and protein levels. Furthermore, stable expression of FOXA1 was found to reduce the mRNA and protein expression of Slug, a repressor of E-cadherin expression. FOXA1 knockdown in the epithelial breast cancer MCF7 cells reduced E-cadherin protein expression without decreasing its mRNA expression. In addition, FOXA1 knockdown in MCF7 cells up-regulated Slug mRNA and protein expression. Notably, similar to FOXA1 knockdown, stable expression of Slug in MCF7 cells reduced E-cadherin protein expression without decreasing its mRNA expression. Taken together, these results suggest that although FOXA1 can induce E-cadherin mRNA expression, it preferentially promotes E-cadherin expression at the protein level by suppressing Slug expression in epithelial breast cancer, and that the balance of this FOXA1-Slug axis regulates EMT progression.

Entities:  

Keywords:  E-cadherin; Slug; epithelial–mesenchymal transition; estrogen receptor; forkhead box protein A1

Mesh:

Substances:

Year:  2017        PMID: 28867731     DOI: 10.1248/bpb.b17-00307

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer.

Authors:  Dorra BenAyed-Guerfali; Emna Dabbèche-Bouricha; Wajdi Ayadi; Fatma Trifa; Slim Charfi; Abdelmajid Khabir; Tahia Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Mol Biol Rep       Date:  2019-04-02       Impact factor: 2.316

2.  Association between breast cancer cell migration and radiosensitivity in vitro.

Authors:  Jing Hou; Leilei Li; Haizhen Zhu; Huan Chen; Na Wei; Min Dai; Qing Ni; Xiaomao Guo
Journal:  Oncol Lett       Date:  2019-10-31       Impact factor: 2.967

3.  FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers.

Authors:  Nihel Ammous-Boukhris; Wajdi Ayadi; Mariem Derbel; Nesrine Allaya-Jaafar; Slim Charfi; Jamel Daoud; Tahya Sellami-Boudawara; Raja Mokdad-Gargouri
Journal:  Biomed Res Int       Date:  2020-06-22       Impact factor: 3.411

4.  Long non-coding RNA RGMB-AS1 represses nasopharyngeal carcinoma progression via binding to forkhead box A1.

Authors:  Tian Zhang; Ying Jin; Xiangmei Luo
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

5.  Vestigial-like family member 3 stimulates cell motility by inducing high-mobility group AT-hook 2 expression in cancer cells.

Authors:  Naoto Hori; Yuki Takakura; Ayumi Sugino; Shuto Iwasawa; Kota Nomizo; Naoto Yamaguchi; Hiroyuki Takano; Noritaka Yamaguchi
Journal:  J Cell Mol Med       Date:  2022-04-02       Impact factor: 5.295

6.  FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact.

Authors:  Jasna Metovic; Fulvio Borella; Marta D'Alonzo; Nicoletta Biglia; Luca Mangherini; Cristian Tampieri; Luca Bertero; Paola Cassoni; Isabella Castellano
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

7.  Rational discovery of antimetastatic agents targeting the intrinsically disordered region of MBD2.

Authors:  Min Young Kim; Insung Na; Ji Sook Kim; Seung Han Son; Sungwoo Choi; Seol Eui Lee; Ji-Hun Kim; Kiseok Jang; Gil Alterovitz; Yu Chen; Arjan van der Vaart; Hyung-Sik Won; Vladimir N Uversky; Chul Geun Kim
Journal:  Sci Adv       Date:  2019-11-20       Impact factor: 14.136

8.  Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship.

Authors:  Qing Zhu; Ligao Wu; Mingyang Tang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.